Hodgkin's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Hodgkin's Disease, including details on causes, cancer, lymphoma, stages, symptoms.

Volume 2 (2005), Issue 7 (July)

1. Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease: potential for a prognostic factor.
   Cancer Res, 65(13): 5516-9. [Abstract] [Full-text]
2. Histological classification of 1,025 cases of Hodgkin's lymphoma from the State of São Paulo, Brazil.
   Sao Paulo Med J, 123(3): 134-6. [Abstract] [Full-text]
3. Late cardiac toxicity secondary to treatment in Hodgkin's disease. A study comparing doxorubicin, epirubicin and mitoxantrone in combined therapy.
   Leuk Lymphoma, 46(7): 1023-8. [Abstract] [Full-text]
4. Successful mobilization of peripheral blood stem cells with the DHAP regimen (dexamethasone, cytarabine, cisplatinum) plus granulocyte colony-stimulating factor in patients with relapsed Hodgkin's disease.
   Leuk Lymphoma, 46(7): 1017-22. [Abstract] [Full-text]
5. Successful treatment of extranodal Hodgkin's lymphoma in a patient with longstanding hairy cell leukemia.
   Leuk Lymphoma, 46(5): 765-9. [Abstract] [Full-text]
6. Alopecia areata and multifocal bone involvement in a young adult with Hodgkin's disease.
   Leuk Lymphoma, 46(4): 623-7. [Abstract] [Full-text]
7. The plateled-derived growth factor level (PDGF) in Hodgkin's disease and non-Hodgkin's lymphoma and its relationship disease activation.
   Hematology, 10(1): 53-7. [Abstract] [Full-text]
8. Gonadal protection by a gonadotropin-releasing hormone agonist depot in young women with Hodgkin's disease undergoing chemotherapy.
   Gynecol Endocrinol, 20(5): 274-8. [Abstract] [Full-text]
9. Germline mutations and polymorphisms in the NFKBIA gene in Hodgkin lymphoma.
   Int J Cancer, 116(4): 646-51. [Abstract] [Full-text]
10. Treatment of refractory Hodgkin's lymphoma patients with an iodine-131-labeled murine anti-CD30 monoclonal antibody.
    J Clin Oncol, 23(21): 4669-78. [Abstract] [Full-text]
11. Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group.
    J Clin Oncol, 23(21): 4634-42. [Abstract] [Full-text]
12. High-dose sequential chemotherapy followed by autologous stem cell transplantation in relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a multicenter phase II study.
    Ann Oncol, 16(8): 1359-65. [Abstract] [Full-text]
13. Hodgkin's lymphoma in elderly patients: a comprehensive retrospective analysis from the German Hodgkin's Study Group.
    J Clin Oncol, 23(22): 5052-60. [Abstract] [Full-text]
14. 18F-FDG PET in malignant lymphoma: significance of positive findings.
    Eur J Nucl Med Mol Imaging, 32(7): 749-56. [Abstract] [Full-text]

© 2004-2008 Hodgkin's Disease Research Today. All Rights Reserved.